Press release
Cancer Gene Therapy Market: Transforming Oncology with Next-Generation Genetic Interventions
The global cancer gene therapy market is witnessing exponential growth, fueled by scientific breakthroughs in genetic engineering, increasing regulatory approvals, and the shift toward precision oncology. Valued at USD 3.89 billion in 2024, the market is projected to reach USD 17.57 billion by 2033, reflecting a CAGR of 18.24% during the forecast period.
๐๐ก๐ ๐๐๐ช๐ฎ๐๐ฌ๐ญ ๐จ๐ ๐ญ๐ก๐ข๐ฌ ๐ฌ๐๐ฆ๐ฉ๐ฅ๐ ๐๐๐ฉ๐จ๐ซ๐ญ ๐๐๐ซ๐: -https://www.astuteanalytica.com/request-sample/cancer-gene-therapy-market
The Rise of Gene Therapy as a Game-Changer in Cancer Treatment
Rising cancer prevalence worldwide is a key driver, with 28 million new cancer cases expected by 2040.
Personalized gene therapy approaches are revolutionizing treatment strategies, offering targeted, curative solutions while minimizing side effects.
Cancer gene therapies represent a high-value segment, with spending on cell and gene therapies reaching USD 5.9 billion in 2023, marking a 38% increase year-over-year.
The field has witnessed a surge in clinical trials, with 171 trials terminated, suspended, or withdrawn, emphasizing the intense focus on developing breakthrough therapies.
Regulatory agencies, including the FDA and EMA, are expediting approvals, with several gene therapies for cancer securing accelerated pathways.
The emergence of gene therapy as a transformative oncology solution is fostering strategic investments, innovative payment models, and expanded market opportunities. As biotech firms, pharmaceutical giants, and academic institutions intensify their focus on gene therapy, the oncology landscape is set to shift toward genetic-based interventions, offering hope for curative cancer treatments.
๐๐๐ซ๐ค๐๐ญ ๐๐ฒ๐ง๐๐ฆ๐ข๐๐ฌ
๐๐ซ๐ข๐ฏ๐๐ซ: Regulatory Approvals Accelerating the Expansion of Cancer Gene Therapy
The growing momentum of regulatory approvals is significantly boosting innovation and patient access to gene therapies for cancer.
In 2023, the FDA approved 55 novel therapeutics, the second-highest count in 30 years, including multiple gene therapies for oncology applications.
The FDA has approved over 300 accelerated applications, many for cancer gene therapies, underscoring the urgency of fast-tracking innovative treatments.
Nine CAR-T cell therapies have been approved for hematological cancers in the U.S. and EU, demonstrating strong regulatory support for autologous gene-modified treatments.
The FDA's newly established Office of Therapeutic Products (OTP) is designed to streamline cell and gene therapy approvals, ensuring faster market entry.
This regulatory landscape reflects the increasing acceptance of gene therapy as a mainstream cancer treatment, paving the way for wider adoption and commercial success.
๐๐ซ๐๐ง๐: ๐๐ข๐ฌ๐ ๐จ๐ ๐๐จ๐ง-๐๐ข๐ซ๐๐ฅ ๐๐๐ง๐ ๐๐๐ฅ๐ข๐ฏ๐๐ซ๐ฒ ๐๐๐๐ญ๐จ๐ซ๐ฌ ๐๐ง๐ก๐๐ง๐๐ข๐ง๐ ๐๐๐๐๐ญ๐ฒ ๐๐ง๐ ๐๐๐๐ข๐๐ข๐๐ง๐๐ฒ
A significant shift in the cancer gene therapy market is the move toward non-viral gene delivery systems, which address safety concerns while improving treatment efficacy.
Lipid nanoparticles (LNPs) have gained prominence due to their successful use in mRNA-based COVID-19 vaccines and are now being explored for cancer gene therapy applications.
Polymeric nanoparticles, such as PAMAM dendrimers and polyethyleneimine (PEI), offer high gene-loading capacity with improved biocompatibility.
Single-chain cyclic polymers (SCKPs) are emerging as a novel gene vector, providing higher stability and targeted gene delivery.
Functionalized non-viral vectors with targeting and imaging capabilities are enabling real-time gene delivery monitoring in clinical settings.
These innovations are set to overcome the limitations of viral vectors, ensuring safer, more efficient, and scalable cancer gene therapy solutions.
๐๐ก๐๐ฅ๐ฅ๐๐ง๐ ๐: ๐๐จ๐ง-๐๐ฉ๐๐๐ข๐๐ข๐ ๐๐๐ง๐ ๐๐ฑ๐ฉ๐ซ๐๐ฌ๐ฌ๐ข๐จ๐ง ๐๐ง๐ ๐๐ง๐๐๐๐ข๐๐ข๐๐ง๐ญ ๐๐๐ฅ๐ข๐ฏ๐๐ซ๐ฒ ๐๐ฒ๐ฌ๐ญ๐๐ฆ๐ฌ ๐๐ข๐ง๐๐๐ซ๐ข๐ง๐ ๐๐ซ๐๐๐ข๐ฌ๐ข๐จ๐ง ๐๐ง๐๐จ๐ฅ๐จ๐ ๐ฒ
Despite rapid advancements, achieving precise, tumor-specific gene delivery remains a key challenge in cancer gene therapy.
Viral vectors often lead to widespread gene expression, increasing the risk of off-target effects and toxicity.
The use of strong viral promoters (e.g., CMV promoter) can induce unwanted gene expression in non-cancerous tissues, reducing specificity.
Gene transfer efficiencies for non-viral vectors are 1/10th to 1/1000th that of viral vectors, posing barriers to widespread adoption.
Challenges in cellular uptake and endosomal escape further limit the effectiveness of gene delivery.
๐๐จ ๐ญ๐๐๐ค๐ฅ๐ ๐ญ๐ก๐๐ฌ๐ ๐ฅ๐ข๐ฆ๐ข๐ญ๐๐ญ๐ข๐จ๐ง๐ฌ, ๐ซ๐๐ฌ๐๐๐ซ๐๐ก๐๐ซ๐ฌ ๐๐ซ๐:
Developing tumor-specific promoters (e.g., hTERT promoter) to restrict gene expression to cancer cells only.
Exploring iron-based nanomaterials and photothermal strategies to enhance targeting and intracellular gene delivery.
Introducing stimuli-responsive delivery systems that activate gene expression only in tumor microenvironments.
These breakthroughs in gene delivery platforms are critical for improving therapy precision and patient safety, ensuring the long-term viability of gene therapy in oncology.
๐๐๐๐ ๐๐๐ญ๐๐ข๐ฅ๐๐ ๐๐ง๐๐๐ฑ ๐จ๐ ๐ ๐ฎ๐ฅ๐ฅ ๐๐๐ฌ๐๐๐ซ๐๐ก ๐๐ญ๐ฎ๐๐ฒ ๐๐ญ @ย https://www.astuteanalytica.com/industry-report/cancer-gene-therapy-market
๐๐จ๐ฉ ๐๐จ๐ฆ๐ฉ๐๐ง๐ข๐๐ฌ ๐ข๐ง ๐๐๐ง๐๐๐ซ ๐๐๐ง๐ ๐๐ก๐๐ซ๐๐ฉ๐ฒ ๐๐๐ซ๐ค๐๐ญ:
Abeona Therapeutics Inc.
Adaptimmune Limited
Aduro Biotech
Altor Bioscience Inc.
Asklepios BioPharmaceutical Inc.
BioCancell Inc.
Bluebird bio Inc.
Bristol Myers
CelgeneInc
Elevate BioInc
Genelux Corporation
GenVec
GSK plc.
Introgen TherapeuticsInc
MerckKGaA
Novartis AG
OncoGenex Pharmaceuticals Inc.
Orchard Therapeutics Plc
Other Prominent Players
๐๐๐ซ๐ค๐๐ญ ๐๐๐ ๐ฆ๐๐ง๐ญ๐๐ญ๐ข๐จ๐ง ๐๐ฏ๐๐ซ๐ฏ๐ข๐๐ฐ:
๐๐ฒ ๐๐ก๐๐ซ๐๐ฉ๐ฒ
Gene Induced Immunotherapy
Gene Transfer
Oncolytic Virotherapy
๐๐ฒ ๐๐ง๐-๐๐ฌ๐๐ซ
Biopharmaceutical Companies
Diagnostic centers
Hospitals
Research Institutes
Others
๐๐ฒ ๐๐๐ ๐ข๐จ๐ง
North America
The USA
Canada
Mexico
Europe
Western Europe
The UK
Germany
France
Italy
Spain
Rest of Western Europe
Eastern Europe
Poland
Russia
Rest of Eastern Europe
Asia Pacific
China
India
Japan
Australia & New Zealand
South Korea
Rest of Asia Pacific
Middle East & Africa
Saudi Arabia
South Africa
UAE
Rest of MEA
South America
Argentina
Brazil
Rest of South America
๐ ๐ฎ๐ญ๐ฎ๐ซ๐ ๐๐ฎ๐ญ๐ฅ๐จ๐จ๐ค: The Next Phase of Cancer Gene Therapy Innovations
With breakthrough therapies, regulatory backing, and significant investment influx, the cancer gene therapy market is on the cusp of a major transformation.
๐๐๐ฒ ๐๐๐ฏ๐๐ฅ๐จ๐ฉ๐ฆ๐๐ง๐ญ๐ฌ ๐ญ๐จ ๐๐๐ญ๐๐ก ๐ข๐ง ๐ญ๐ก๐ ๐๐๐ฑ๐ญ ๐๐๐๐๐๐:
Advancements in CRISPR-based cancer therapies, enabling gene editing at the molecular level to correct mutations.
Expansion of gene therapy applications into solid tumors, overcoming previous limitations of CAR-T cell therapies.
Integration of AI-driven drug discovery platforms, accelerating gene therapy development timelines.
Development of modular gene circuits, allowing for more precise gene regulation in cancer treatments.
Increased adoption of novel payment models, such as value-based reimbursement for high-cost therapies.
With its potential to redefine oncology treatment, cancer gene therapy is positioned as one of the most disruptive forces in modern medicine. Companies that invest in next-generation delivery systems, personalized approaches, and AI-powered analytics will lead the charge in shaping the future of precision cancer care.
๐๐๐ญ ๐ ๐๐๐ฆ๐ฉ๐ฅ๐ ๐๐๐ ๐จ๐ ๐ญ๐ก๐ ๐๐๐ฉ๐จ๐ซ๐ญ:-https://www.astuteanalytica.com/request-sample/cancer-gene-therapy-market
market
๐๐๐จ๐ฎ๐ญ ๐๐ฌ๐ญ๐ฎ๐ญ๐ ๐๐ง๐๐ฅ๐ฒ๐ญ๐ข๐๐:
Astute Analytica is a global analytics and advisory company that has built a solid reputation in a short period, thanks to the tangible outcomes we have delivered to our clients. We pride ourselves in generating unparalleled, in-depth, and uncannily accurate estimates and projections for our very demanding clients spread across different verticals. We have a long list of satisfied and repeat clients from a wide spectrum including technology, healthcare, chemicals, semiconductors, FMCG, and many more. These happy customers come to us from all across the globe.
They are able to make well-calibrated decisions and leverage highly lucrative opportunities while surmounting the fierce challenges all because we analyse for them the complex business environment, segment-wise existing and emerging possibilities, technology formations, growth estimates, and even the strategic choices available. In short, a complete package. All this is possible because we have a highly qualified, competent, and experienced team of professionals comprising business analysts, economists, consultants, and technology experts. In our list of priorities, you-our patron-come at the top. You can be sure of the best cost-effective, value-added package from us, should you decide to engage with us.
๐๐๐ญ ๐ข๐ง ๐ญ๐จ๐ฎ๐๐ก ๐ฐ๐ข๐ญ๐ก ๐ฎ๐ฌ
๐๐ก๐จ๐ง๐ ๐ง๐ฎ๐ฆ๐๐๐ซ: +18884296757
๐๐ฆ๐๐ข๐ฅ: sales@astuteanalytica.com
๐๐ข๐ฌ๐ข๐ญ ๐จ๐ฎ๐ซ ๐ฐ๐๐๐ฌ๐ข๐ญ๐:ย https://www.astuteanalytica.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Cancer Gene Therapy Market: Transforming Oncology with Next-Generation Genetic Interventions here
News-ID: 3858401 • Views: โฆ
More Releases from Astute Analytica
Global Street Sweeper Market Valued at US$ 2,287.17 Million in 2024, Expected to โฆ
Introduction: Street Sweeper Market Shows Steady Growth Amid Urbanization
The global street sweeper market was valued at US$ 2,287.17 million in 2024 and is projected to reach US$ 3,282.05 million by 2033, growing at a compound annual growth rate (CAGR) of 4.13% during the forecast period from 2025 to 2033. Rising urbanization, increasing government initiatives for cleaner cities, and the growing need for efficient waste management solutions are driving this steadyโฆ
U.S. Glass Cleaner Market to Grow from US$ 832.5 Million in 2024 to US$ 1,556.4 โฆ
Introduction: Market Overview
The U.S. glass cleaner market is experiencing robust growth, driven by rising consumer demand for cleanliness, hygiene awareness, and the expansion of the commercial and residential sectors. Valued at US$ 832.5 million in 2024, the market is projected to reach US$ 1,556.4 million by 2033, reflecting a healthy compound annual growth rate (CAGR) of 7.2% during the forecast period of 2025-2033.
Gain Crystal-Clear Market Overview: Get Your Copy: -https://www.astuteanalytica.com/request-sample/us-glass-cleaner-market
Glassโฆ
Japan Processed Meat Market to Reach US$ 20.27 Billion by 2033, Growing at a CAG โฆ
The Japan processed meat market is witnessing robust growth, with the market valued at US$ 12.88 billion in 2024 and projected to attain US$ 20.27 billion by 2033, reflecting a compound annual growth rate (CAGR) of 5.32% during the forecast period from 2025 to 2033. This expansion is driven by evolving consumer preferences, increasing demand for convenient food options, and the growing adoption of processed meat products across urban andโฆ
Global Organic Wine Market to Soar from US$ 12.14 Billion in 2024 to US$ 30.06 B โฆ
Global Organic Wine Market Shows Robust Growth Driven by Health-Conscious Consumers and Sustainable Practices
The global organic wine market is on a significant growth trajectory, with market valuation rising from US$ 12.14 billion in 2024 to an anticipated US$ 30.06 billion by 2033, registering a compound annual growth rate (CAGR) of 10.6% during the forecast period 2025-2033. The growth is fueled by increasing consumer awareness of health, wellness, and sustainable agriculturalโฆ
More Releases for Gene
DNA and Gene Cloning Services Market Expands with Growing Focus on Complex Gene โฆ
InsightAce Analytic Pvt. Ltd. has announced the publication of a market research report titled "Global DNA and Gene Cloning Services Market by Type of Service Offered (Custom Cloning, Sub-cloning, Gene Synthesis, and Others), Type of Gene (Complex Gene, Standard Gene, and Others), End-User Industry (Pharmaceutical, Academic and R&D, and Biotechnology Companies, and Others)- Market Outlook and Industry Analysis 2034"
The DNA and Gene Cloning Services Market Size is valuedโฆ
Evolving Market Trends In The CRISPR Gene Editing Industry: Innovative Gene Ther โฆ
The CRISPR Gene Editing Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Expected CRISPR Gene Editing Market Size During the Forecast Period?
The CRISPR gene editing market has grown exponentially in recent years. It will grow from $2.26 billion in 2024 to $2.88โฆ
Cell and Gene Therapy Market Global Analysis By Type (Cell Therapy, Gene Therapy โฆ
Gene and cell therapy uses genes and cells for the treatment of genetic diseases. Genetic diseases are caused by mutations, or errors in genes which can be passed down from one generation to another. Gene therapy aims to treat diseases by using genetic material, or DNA, to manipulate a patient's cells by replacing, changing or introducing genome into cells- either internally or externally. Cell therapy aims to treat diseases byโฆ
Competitive and Opportunities Analysis of Gene Therapy Market of Gene Therapy Ma โฆ
Global Gene Therapy Market accounted for US$ 2.05 billion in 2020 and is estimated to be US$ 12.29 billion by 2030 and is anticipated to register a CAGR of 19.8%. Gene therapy means fixing a working gene to an individual who features a damaged gene. The European Commission has approved this method for one particular treatment. The treatment by the merchandise Glybera uses an epidemic to infect muscle cells withโฆ
Genetic Testing Market Size by Growth Opportunities, Top Key Players: GeneDx, In โฆ
Genetic Testing Market Report provides an in-depth analysis of the overall market, The ripple effect of Coronavirus-Covid19 on the market needs to become part of strategy discussions to emerge strong. The report focuses on major key players, production details, their application, countries and also analyzes the global and key regions market potential and advantage, opportunity, and challenge, restraints, and risks.
The Top players Covered in report are GeneDx, Invitae, Pathway Genomics,โฆ
Gene Synthesis Market by Top Manufacturers - Gene script, Gene Art (Thermofische โฆ
The "Gene Synthesis Market" report Added by "Big Market Research", enumerates information about the industry in terms of market share, market size, revenue forecasts, and regional outlook. The report further illustrates competitive insights of key players in the business vertical followed by an overview of their diverse portfolios and growth strategies.
In the Gene Synthesis Market 2018 research report professionals describe the different facets of the industry with a specific goalโฆ
